
               
               
               7 DRUG INTERACTIONS
               
               
                  
                     
                     
                     7.1     MAO Inhibitors
                     
                        Do not administer QUILLIVANT XR concomitantly with monoamine oxidase inhibitors (MAOIs) or within 14 days after discontinuing MAOI treatment. Concomitant use of MAOIs and CNS stimulants can cause hypertensive crisis. Potential outcomes include death, stroke, myocardial infarction, aortic dissection, ophthalmological complications, eclampsia, pulmonary edema, and renal failure.
                     
                     
                  
               
            
         